Knowledge Center
Article / Mar 08, 2017
Expanding the Commercial Options
Source:
Pharma's Almanac, Q1 2017, Mar 8, 2017
Spray drying (SD) and hot-melt extrusion (HME) are commercially proven and accepted amorphous solid dispersion (ASD) technologies for the enhancement of the dissolution and bioavailability of poorly soluble drugs. These approaches are not suitable for all APIs, however. Hovione, in addition to offering non-ASD solutions such as nanomilling and cyclodextrin complexation, is developing an effective coprecipitation technology platform to address this key market need.
Related links
Also in the Knowledge Center
/ May 29, 2025
Mitigating Shear Stress in Spray Drying for RNA‑Loaded Lipid Nanoparticles through Process and Formulation Optimization
Read more
Scientific Article
/ Jun 01, 2025
Improving inhalation delivery of biologics with extra-large particles produced by spray freeze drying
Read more
Scientific Article
/ Jun 20, 2025
Material-sparing method development for liquid-to-solid ratio determination for wet granulation process development
Read more
Scientific Article